Immunocore Limited are the world’s leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases.
Following the success of Buildings 91 and 96 completed in 2018, S+B worked closely with the client to develop the new scheme for Building 92 which is currently unused.
Al worktops will be made of Trespa Toplab Base, supported on Utilaire H frames and will have mobile units under for easy reconfiguration.
S+B will also supply loose furniture and 7 ducted Ecoline fume hoods.
Our team will be on site in November and install a total of 24 laboratories.